Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-01-12

Clinical Trial Update: A Feasibility Study of Prophylactic White Blood Cell Transfusions [Phase 2]

View source ↗

Summary

Phase 2 feasibility study evaluating prophylactic white blood cell transfusions in leukemia patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 2 | Status: COMPLETED